A
Ascendis Pharma
Biotech & Life Sciences · Gentofte Municipality, Denmark · Founded 2007 · IPO 2015 Decacorn
Global footprint
Where Ascendis Pharma has talent and traffic
(3 of 1,370 staff)
team presence
across markets
Patent intelligence
$275M patent portfolio · 112 active families
Where Ascendis Pharma concentrates vs peers
Each axis is a top-10 topic across Ascendis Pharma and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Capital deployed
Ascendis Pharma's 3 investments and acquisitions.
Every disclosed deal where Ascendis Pharma appeared as a backer or acquirer, 2018–2023. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across Ascendis Pharma's capital deployment.
Where the deals concentrate by sector, stage, and decade.
01 · Deployment strategy vs peers
Where Ascendis Pharma deploys vs peers
Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.
02 · Portfolio market map
Ascendis Pharma's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about Ascendis Pharma
An AI-synthesized read of the highest-engagement posts about Ascendis Pharma on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ascendis Pharma on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.